Advanced Search

Technical Analysis for ABIO - ARCA biopharma, Inc.

Grade Last Price % Change Price Change
grade B 6.72 -3.31% -0.23
ABIO closed down 3.31 percent on Tuesday, July 14, 2020, on 26 percent of normal volume. It was able to find support at its 50 day moving average.
Earnings due: Jul 30
*** please verify all earnings dates ***
7 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical ABIO trend table...
Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
50 DMA Support Bullish 0.00%
Crossed Above 20 DMA Bullish -3.31%
Pocket Pivot Bullish Swing Setup -3.31%
Upper Bollinger Band Touch Strength -3.31%
Narrow Range Bar Range Contraction 1.97%
20 DMA Resistance Bearish -0.30%
Pocket Pivot Bullish Swing Setup -0.30%
Oversold Stochastic Weakness -0.30%
50 DMA Support Bullish 0.45%
Older EOD signals for ABIO ...
View Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators Basic chart:

Profile

ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction. ARCA biopharma, Inc. is headquartered in Broomfield, Colorado.
Biopharmaceutical Anatomy Heart Failure Cardiovascular Diseases Atrial Fibrillation Cardiac Arrhythmia Heart Diseases Ventricular Dysfunction

Is ABIO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Jul 14 Arca biopharma ups stock sales agreement with JonesTrading
Jul 7 SARS-CoV-2 Cell Entry Mechanisms in Intact Human Heart Published in JACC: Basic to Translational Science by University of Colorado Anschutz Medical Campus and ARCA biopharma Investigators
Jun 3 ARCA biopharma Announces Closing of $6.1 Million Registered Direct Offering
Jun 3 Biotech Stock Roundup: GILD's Coronavirus Drug Update, NTLA-REGN Deal & More
Jun 1 ARCA bio plummets 20% on $9.4M direct offering
Jun 1 ARCA Biopharma Announces $9.4 Million Registered Direct Offering
May 30 The Week Ahead In Biotech: ASCO, Menlo And Merck FDA Decisions, IPOs In The Spotlight
May 29 A Mighty May: Over $200,000 In Gross Profits
May 29 Company News for May 29, 2020
May 29 The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant
See more ABIO news...

Indicators

Indicator Value
52 Week High 22.0
52 Week Low 2.21
Average Volume 2,130,146
200-Day Moving Average 5.18
50-Day Moving Average 6.47
20-Day Moving Average 6.85
10-Day Moving Average 6.66
Average True Range 0.78
ADX 44.96
+DI 32.40
-DI 12.86
Chandelier Exit (Long, 3 ATRs ) 5.45
Chandelier Exit (Short, 3 ATRs ) 8.53
Upper Bollinger Band 7.37
Lower Bollinger Band 6.33
Percent B (%b) 0.38
BandWidth 15.23
MACD Line -0.04
MACD Signal Line 0.02
MACD Histogram -0.0542
Fundamentals Value
Market Cap 78.93 Million
Num Shares 11.7 Million
EPS -2.05
Price-to-Earnings (P/E) Ratio -3.28
Price-to-Sales 0.00
Price-to-Book 0.92
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.56
Resistance 3 (R3) 7.55 7.26 7.42
Resistance 2 (R2) 7.26 7.05 7.27 7.37
Resistance 1 (R1) 6.99 6.91 6.85 7.00 7.33
Pivot Point 6.70 6.70 6.63 6.71 6.70
Support 1 (S1) 6.43 6.49 6.29 6.44 6.11
Support 2 (S2) 6.14 6.35 6.15 6.07
Support 3 (S3) 5.87 6.14 6.02
Support 4 (S4) 5.88